Treatments for metastatic melanoma: Synthesis of evidence from randomized trials
- 31 December 2007
- journal article
- research article
- Published by Elsevier BV in Cancer Treatment Reviews
- Vol. 33 (8), 665-680
- https://doi.org/10.1016/j.ctrv.2007.06.004
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Randomized trial of dacarbazine versus bleomycin, vincristine, lomustine and dacarbazine (BOLD) chemotherapy combined with natural or recombinant interferon-?? in patients with advanced melanomaMelanoma Research, 2005
- The current role of systemic therapy in the management of Malignant Melanoma of the skin: a literature reviewJournal of Radiotherapy in Practice, 2004
- Treatment of Brain Metastases From MelanomaMayo Clinic Proceedings, 2003
- Use of tamoxifen in the treatment of malignant melanomaCancer, 2003
- Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen, or vindesine plus tamoxifenMelanoma Research, 2003
- Dacarbazine–vindesine versus dacarbazine–vindesine–cisplatin in disseminated malignant melanoma. A randomised phase III trialEuropean Journal of Cancer, 1998
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Phase II study of vindesine and dacarbazine with or without non-specific stimulation of the immune system in patients with metastatic melanomaEuropean Journal of Cancer, 1993
- Cytotoxic chemotherapy of disseminated cutaneous malignant melanoma—A prospective and randomized clinical trial of procarbazine, vindesine and lomustine versus procarbazine, DTIC and lomustineEuropean Journal of Cancer and Clinical Oncology, 1986
- Therapy of malignant melanoma with an imidazole carboxamide and bis-chloroethyl nitrosoureaCancer, 1972